Sintilimab, produced by Simcoe , represents a crucial advance in cancer therapy . This antibody medicine is a PD-1 blocker , intended to unlock the body's defense against tumors . Research trials have demonstrated remarkable outcomes , particularly in conjunction with chemotherapy , showing poten